Astrana Health Stock Current Valuation
Valuation analysis of Astrana Health helps investors to measure Astrana Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Astrana Health Company Current Valuation Analysis
Astrana Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Astrana Health Current Valuation | 1.81 B |
Most of Astrana Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Astrana Health has a Current Valuation of 1.81 B. This is 87.37% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 89.09% higher than that of the company.
Astrana Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in current valuation category among its peers.
Astrana Fundamentals
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.81 B | |||
| Shares Outstanding | 45.45 M | |||
| Shares Owned By Insiders | 25.77 % | |||
| Shares Owned By Institutions | 46.99 % | |||
| Number Of Shares Shorted | 2.75 M | |||
| Price To Earning | 28.18 X | |||
| Price To Book | 3.12 X | |||
| Price To Sales | 1.40 X | |||
| Revenue | 1.33 B | |||
| Gross Profit | 199.48 M | |||
| EBITDA | 117.97 M | |||
| Net Income | 48.51 M | |||
| Cash And Equivalents | 273.71 M | |||
| Cash Per Share | 6.04 X | |||
| Total Debt | 229.36 M | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 2.49 X | |||
| Book Value Per Share | 12.74 X | |||
| Cash Flow From Operations | 133.87 M | |||
| Short Ratio | 17.16 X | |||
| Earnings Per Share | 1.04 X | |||
| Target Price | 46.56 | |||
| Number Of Employees | 1.36 K | |||
| Beta | 1.04 | |||
| Market Capitalization | 1.86 B | |||
| Total Asset | 966.21 M | |||
| Retained Earnings | 192.68 M | |||
| Working Capital | 287.81 M | |||
| Current Asset | 13.56 M | |||
| Current Liabilities | 7.43 M | |||
| Z Score | 7.27 | |||
| Net Asset | 966.21 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |